222 related articles for article (PubMed ID: 29327178)
1. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
[TBL] [Abstract][Full Text] [Related]
3. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
6. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.
Sun C; Anraku M; Karasaki T; Kuwano H; Nagayama K; Nitadori JI; Sato M; Nakajima J
Eur J Cardiothorac Surg; 2019 Mar; 55(3):414-420. PubMed ID: 30289481
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative computed tomography-determined quantity and quality of skeletal muscle on survival after resected non-small cell lung carcinoma.
Çınar HU; Çelik B; Taşkın G; İnce Ö
Eur J Surg Oncol; 2022 Sep; 48(9):1937-1946. PubMed ID: 35361518
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
[TBL] [Abstract][Full Text] [Related]
9. Preoperative small airway dysfunction is associated with skeletal muscle loss in early-stage non-small cell lung cancer.
Jia QC; Niu Y; Qin L; Yuan JR; Liu PP; Liu L; Miao SD; Wang RT; Meng QW
Clin Nutr; 2023 Oct; 42(10):1932-1939. PubMed ID: 37634307
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
[TBL] [Abstract][Full Text] [Related]
11. Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.
Tsukioka T; Izumi N; Kyukwang C; Komatsu H; Toda M; Hara K; Nishiyama N
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):121-126. PubMed ID: 29459570
[TBL] [Abstract][Full Text] [Related]
12. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403.
Matsuo Y; Nagata Y; Wakabayashi M; Ishikura S; Onishi H; Kokubo M; Karasawa K; Shioyama Y; Onimaru R; Hiraoka M
J Radiat Res; 2021 Sep; 62(5):901-909. PubMed ID: 34350956
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of tumor volume on stage I non-small cell lung cancer.
Su XD; Xie HJ; Liu QW; Mo YX; Long H; Rong TH
Lung Cancer; 2017 Feb; 104():91-97. PubMed ID: 28213008
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
[TBL] [Abstract][Full Text] [Related]
16. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
18. Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients With Non-Small Cell Lung Cancer.
Sun C; Anraku M; Kawahara T; Karasaki T; Konoeda C; Kitano K; Sato M; Nakajima J
Ann Surg Oncol; 2022 Mar; 29(3):1816-1824. PubMed ID: 34997412
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
